Allergan drops appeal of order blocking Alzheimer's drug switch
November 25, 2015 at 12:13 PM EST
Nov 25 (Reuters) - Allergan PLC said on Wednesday it will not appeal to the U.S. Supreme Court a court ruling this year that blocked the company from discontinuing its top-selling Alzheimer's drug in favor of a pricier version.
